6109 studies found for:    "Breast Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
"Breast Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
Re-expression of ER in Triple Negative Breast Cancers
Conditions: Breast Cancer;   Breast Tumors;   Breast Neoplasms
Intervention: Drug: Decitabine, LBH589, Tamoxifen
2 Terminated
Has Results
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer;   Cancer of the Breast
Intervention: Drug: Lapatinib and Everolimus
3 Active, not recruiting Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer;   Breast Tumors;   Cancer of the Breast;   Neoplasms, Breast;   Tumors, Breast
Interventions: Drug: Eribulin;   Drug: Doxorubicin;   Drug: Cyclophosphamide
4 Active, not recruiting Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer;   Breast Tumors;   Cancer of Breast;   Cancer of the Breast;   Human Mammary Carcinoma;   Neoplasms, Breast
Interventions: Procedure: Remove tumor only;   Procedure: Removal of tumor and tissue
5 Active, not recruiting Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasms;   Breast Tumors;   Cancer;   Locally Recurrent and Metastatic Breast Cancer;   Metastases;   Metastatic Cancer;   Oncology;   Solid Tumors;   Tumors
Interventions: Drug: AMG 386 30 mg/kg, Paclitaxel and Trastuzumab;   Drug: AMG 386 30 mg/kg, Capecitabine and Lapatinib;   Drug: AMG 386 10 mgkg, Paclitaxel and Trastuzumab;   Drug: AMG 386 10 mg/kg, Capecitabine and Lapatinib
6 Active, not recruiting Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)
Conditions: Breast Tumor;   Breast Cancer;   Cancer of the Breast;   Estrogen Receptor- Negative Breast Cancer;   HER2- Negative Breast Cancer;   Progesterone Receptor- Negative Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer;   Triple-negative Breast Cancer;   Triple-negative Metastatic Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: nab-Paclitaxel 125 mg/m2 plus carboplatin AUC 2 in triple negative metastatic breast cancer (TNMBC) subjects;   Drug: Carboplatin AUC 2;   Drug: gemcitabine 1000 mg
7 Completed Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer
Conditions: Tubular Breast Cancer Stage II;   Mucinous Breast Cancer Stage II;   Breast Cancer Female NOS;   Invasive Ductal Breast Cancer;   Tubular Breast Cancer Stage III;   HER-2 Positive Breast Cancer;   Inflammatory Breast Cancer Stage IV;   Inflammatory Breast Cancer
Interventions: Drug: Carboplatin;   Drug: background treatment according to standards fpr triple negative and Her2pos breast cancer patients
8 Recruiting Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer
Conditions: Stage 0 Breast Carcinoma;   Breast Neoplasms;   Stage I Breast Carcinoma;   Stage II Breast Carcinoma;   Stage III Breast Carcinoma
Interventions: Drug: Metformin;   Drug: Omega-3 fatty acids
9 Active, not recruiting Study Comparing Nanoparticle-based Paclitaxel With Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Patients With Early Breast Cancer (GeparSepto)
Conditions: Tubular Breast Cancer Stage II;   Mucinous Breast Cancer Stage II;   Breast Cancer Female NOS;   Invasive Ductal Breast Cancer;   Tubular Breast Cancer Stage III;   HER-2 Positive Breast Cancer;   Inflammatory Breast Cancer Stage IV;   Inflammatory Breast Cancer
Interventions: Drug: nab-Paclitaxel;   Drug: Paclitaxel
10 Active, not recruiting Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
Conditions: Breast Cancer;   Cancer of the Breast;   Breast Neoplasm
Interventions: Other: Letrozole (Femara);   Drug: Letrozole; Avastin
11 Recruiting Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Conditions: Breast Cancer;   Breast Neoplasm;   Breast Tumor;   Cancer of the Breast
Intervention: Radiation: Proton Radiotherapy
12 Recruiting GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer
Conditions: Estrogen Receptor Negative Breast Cancer;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast;   Triple Negative Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer;   Triple-negative Breast Cancer
Interventions: Drug: cisplatin;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: dynamic contrast-enhanced MRI, diffusion-weighted MRI & chemical exchange saturation transfer MRI;   Drug: GDC -0941
13 Terminated A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer
Conditions: Breast Neoplasms;   Breast Tumors;   Breast Cancer;   Locally Recurrent and Metastatic Breast Cancer
Interventions: Drug: AMG 706 placebo;   Drug: Bevacizumab;   Drug: AMG 706
14 Completed Multipeptide Vaccine for Advanced Breast Cancer
Conditions: Breast Neoplasm;   Breast Cancer;   Cancer of the Breast;   Carcinoma, Ductal
Intervention: Biological: hTERT/Survivin Multi-Peptide Vaccine
15 Completed Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
Conditions: Colorectal Cancer;   Colon Cancer;   Rectal Cancer;   Colorectal Neoplasms;   Colorectal Carcinoma;   Breast Cancer;   Breast Neoplasms
Intervention: Drug: hMN14 (labetuzumab)
16 Completed
Has Results
Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer
Interventions: Drug: Vinflunine;   Drug: Trastuzumab
17 Recruiting Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer Patients Who Have Failed an Anthracycline (CAT)
Conditions: Breast Neoplasms;   Breast Cancer
Interventions: Drug: Taxane;   Drug: Taxotere;   Drug: Abraxane;   Drug: Ixabepilone
18 Active, not recruiting Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
Conditions: Breast Cancer;   Triple Negative Breast Cancer;   Stage IV Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: Abraxane;   Drug: Tigatuzumab
19 Completed Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer, Metastatic
Intervention: Drug: Sagopilone (BAY86-5302, ZK 219477)
20 Terminated Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Breast Cancer
Intervention: Drug: ertumaxomab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years